The Cardiovascular Complications of Pregnancy

Progress in Cardiovascular Diseases

Volumn 50, Issue 2, 2007, Pages 126-135

  Ward, Cary ^a   Bushnell, Cheryl D ^a   James, Andra H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

AMNION FLUID EMBOLISM; AORTA ANEURYSM; AORTA DISSECTING ANEURYSM; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE PREDISPOSITION; HEALTH CARE; HEART AFTERLOAD; HEART INFARCTION; HEART OUTPUT; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PLASMA VOLUME; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTEMATIC REVIEW; TERATOGENICITY; UNITED STATES; VASODILATATION; VENOUS THROMBOEMBOLISM;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; PATIENT CARE TEAM; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE;

EID: 34548201810     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.02.001     Document Type: Article

References (65)

1. Carbillon L., Uzan M., and Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55 (2000) 574-581
2. Chesley L.C. Hypertension in pregnancy: definitions, familial factor, and remote prognosis. Kidney Int 18 (1980) 234-240
3. Novak J., Reckelhoff J., Bumgarner L., et al. Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats. Hypertension 30 3 Pt 2 (1997) 580-584
4. Bernstein I.M., Ziegler W., and Badger G.J. Plasma volume expansion in early pregnancy. Obstet Gynecol 97 5 Pt 1 (2001) 669-672
5. Desai D.K., Moodley J., and Naidoo D.P. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol 104 (2004) 20-29
6. Jordaan D.J., Schoon M.G., and Badenhorst P.N. Thrombophilia screening in pregnancy. Obstet Gynecol Surv 60 (2005) 394-404
7. Heit J.A., Kobbervig C.E., James A.H., et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 143 (2005) 697-706
8. Borg-Stein J., Dugan S.A., and Gruber J. Musculoskeletal aspects of pregnancy. Am J Phys Med Rehabil/ Assoc Acad Physiatrists 84 (2005) 180-192
9. Cunningham F.G., and Lindheimer M.D. Hypertension in pregnancy. N Engl J Med 326 (1992) 927-932
10. Saftlas A.F., Olson D.R., Franks A.L., et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 163 (1990) 460-465
11. Fretts R.C., Schmittdiel J., McLean F.H., et al. Increased maternal age and the risk of fetal death. N Engl J Med 333 (1995) 953-957
12. Haukkamaa L., Salminen M., Laivuori H., et al. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 93 (2004) 805-808
13. Zhou Y., Damsky C.H., and Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 99 (1997) 2152-2164
14. Sibai B.M. Diagnosis and management of chronic hypertension in pregnancy. Obstet Gynecol 78 3 Pt 1 (1991) 451-461
15. Redman C.W., and Sargent I.L. Preeclampsia and the systemic inflammatory response. Semin Nephrol 24 (2004) 565-570
16. Rumbold A.R., Crowther C.A., Haslam R.R., et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
17. Duley L., Henderson-Smart D., Knight M., et al. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 322 (2001) 329-333
18. Magee L.A., Cham C., Waterman E.J., et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ (Clinical research ed) 327 (2003) 955-960
19. Hjertberg R., Belfrage P., and Hanson U. Conservative treatment of mild and moderate hypertension in pregnancy. Acta Obstet Gynecol Scand 71 (1992) 439-446
20. Sibai B.M., Mabie W.C., Shamsa F., et al. A comparison of no medication vs. methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162 (1990) 960-966 (discussion 6-7)
21. Badui E., and Enciso R. Acute myocardial infarction during pregnancy and puerperium: a review. Angiology 47 (1996) 739-756
22. Roth A., and Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 125 (1996) 751-762
23. James A.H., Jamison M.G., Biswas M.S., et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 113 (2006) 1564-1571 [Electronic publication 2006 Mar 13
24. Ladner H.E., Danielsen B., and Gilbert W.M. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 105 (2005) 480-484
25. Hauth J.C., Goldenberg R.L., Parker Jr. C.R., et al. Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 85 (1995) 1055-1058
26. Rubin P.C. Current concepts: beta-blockers in pregnancy. N Engl J Med 305 (1981) 1323-1326
27. Collins J.S., Bossone E., Eagle K.A., et al. Asymptomatic coronary artery disease in a pregnant patient. A case report and review of literature. Herz 27 (2002) 548-554
28. Koul A.K., Hollander G., Moskovits N., et al. Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature. Catheter Cardiovasc Interv 52 (2001) 88-94
29. Varadarajan P., Isaeff D., and Pai R.G. Prosthetic valve thrombosis presenting as an acute embolic myocardial infarction in a pregnant patient: issues on anticoagulation regimens and thrombolytic therapy. Echocardiography (Mount Kisco, NY) 23 (2006) 774-779
30. Agostoni P., Gasparini G., and Destro G. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman. Heart (British Cardiac Society) 90 (2004) e12
31. Iadanza A., Del Pasqua A., Barbati R., et al. Acute ST elevation myocardial infarction in pregnancy due to coronary vasospasm: a case report and review of literature. Int J Cardiol (2006)
32. James A.H., Bushnell C.D., Jamison M.G., et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 106 (2005) 509-516
33. Petitti D.B., Sidney S., and Quesenberry Jr. C.P. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 28 (1997) 280-283
34. Carod-Artal F.J., da Silveira Ribeiro L., Braga H., et al. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 26 (2006) 934-939
35. Cheng T.O. Patent foramen ovale and migraine. Am J Cardiol 98 (2006) 990-991
36. Giberti L., Bino G., and Tanganelli P. Pregnancy, patent foramen ovale and stroke: a case of pseudoperipheral facial palsy. Neurol Sci 26 (2005) 43-45
37. Daehnert I., Ewert P., Berger F., et al. Echocardiographically guided closure of a patent foramen ovale during pregnancy after recurrent strokes. J Interv Cardiol 14 (2001) 191-192
38. Murugappan A., Coplin W.M., Al-Sadat A.N., et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 66 (2006) 768-770
39. Johnson D.M., Kramer D.C., Cohen E., et al. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke 36 (2005) e53-e55
40. Martin Jr. J.N., Thigpen B.D., Moore R.C., et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 105 (2005) 246-254
41. Sharshar T., Lamy C., and Mas J.L. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 26 (1995) 930-936
42. Lanska D.J., and Kryscio R.J. Stroke and intracranial venous thrombosis during pregnancy and puerperium. Neurology 51 (1998) 1622-1628
43. Ferro J.M., Canhao P., Stam J., et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35 (2004) 664-670
44. de Bruijn S.F., and Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30 (1999) 484-488
45. Selo-Ojeme D.O., Marshman L.A., Ikomi A., et al. Aneurysmal subarachnoid haemorrhage in pregnancy. Eur J Obstet Gynecol Reprod Biol 116 (2004) 131-143
46. Wilterdink J.L., and Feldmann E. Intracranial hemorrhage. Adv Neurol 90 (2002) 63-74
47. Bateman B.T., Schumacher H.C., Bushnell C.D., et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 67 (2006) 424-429
48. James A.H., Jamison M.G., Brancazio L.R., et al. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 194 (2006) 1311-1315 [Electronic publication 2006 Apr 21]
49. James A.H., Bushnell C.D., Jamison M.G., et al. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 106 (2005) 509-516
50. Greer I.A. Anticoagulants in pregnancy. J Thromb Thrombolysis 21 (2006) 57-65
51. McColl M.D., Ramsay J.E., Tait R.C., et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 78 (1997) 1183-1188
52. Bates S.M. Treatment and prophylaxis of venous thromboembolism during pregnancy. Thromb Res 108 (2002) 97-106
53. Ginsberg J.S., Greer I., and Hirsh J. Use of antithrombotic agents during pregnancy. Chest 119 1 Suppl (2001) 122S-131S
54. Hirsh J., Dalen J., Anderson D.R., et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119 1 Suppl (2001) 8S-21S
55. Stone S.E., and Morris T.A. Pulmonary embolism during and after pregnancy. Crit Care Med 33 10 Suppl (2005) S294-S300
56. lNgan Kee W.D., and Khaw K.S. Vasopressors in obstetrics: what should we be using?. Curr Opin Anaesthesiol 19 (2006) 238-243
57. Moore J., and Baldisseri M.R. Amniotic fluid embolism. Crit Care Med 33 10 Suppl (2005) S279-S285
58. Kramer M.S., Rouleau J., Baskett T.F., et al. Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study. Lancet 368 (2006) 1444-1448
59. Gilbert W.M., and Danielsen B. Amniotic fluid embolism: decreased mortality in a population-based study. Obstet Gynecol 93 (1999) 973-977
60. Sliwa K., Forster O., Libhaber E., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27 (2006) 441-446
61. Ansari A.A., Fett J.D., Carraway R.E., et al. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23 (2002) 301-324
62. Sliwa K., Fett J., and Elkayam U. Peripartum cardiomyopathy. Lancet 368 (2006) 687-693
63. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 (2001) 1567-1571
64. Rahman J., Rahman F.Z., Rahman W., et al. Obstetric and gynecologic complications in women with Marfan syndrome. J Reprod Med 48 (2003) 723-728
65. Immer F.F., Bansi A.G., Immer-Bansi A.S., et al. Aortic dissection in pregnancy: analysis of risk factors and outcome. Ann Thorac Surg 76 (2003) 309-314